PFNX Pfenex Inc.

6.24
+0.08  (+1%)
Previous Close 6.16
Open 6.07
Price To Book 3.36
Market Cap 196,572,355
Shares 31,501,980
Volume 186,703
Short Ratio 3.01
Av. Daily Volume 177,997

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

PDUFA date October 7, 2019.
PF708 and Forteo
Osteoporosis
Phase 2 trial to be initiated 2019 subject to funding.
Px563L
Anthrax vaccine
Phase 1/2 data released August 2016. Noted November 9, 2017 that development has been paused until strategic partnerships are forged.
PF582
Biosimilar candidate to Lucentis for retinal diseases
Phase 3 trial of partnered product met primary endpoint - March 6, 2019.
CRM197
Pneumococcal conjugate vaccine

Latest News

  1. Hedge Funds Have Never Been This Bullish On Pfenex Inc (PFNX)
  2. Pfenex Sees Hammer Chart Pattern: Time to Buy?
  3. Edited Transcript of PFNX earnings conference call or presentation 9-May-19 8:30pm GMT
  4. Pfenex to Participate at the JMP Securities Life Sciences Conference
  5. Pfenex and Alvogen Announce European Medicines Agency Accepts Marketing Authorization Application for PF708
  6. Pfenex Inc. (PFNX) Shares March Higher, Can It Continue?
  7. Pfenex (PFNX) Reports Q1 Loss, Tops Revenue Estimates
  8. Pfenex Reports First Quarter 2019 Results and Provides Business Update
  9. Pfenex (PFNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
  10. Pfenex to Announce First Quarter 2019 Financial Results on May 9
  11. Pfenex Appoints Dr. Robert Peach to Scientific Advisory Board
  12. Pfenex Announces Successful Expiration of 45 Day Waiting Period Under Hatch-Waxman Act
  13. Pfenex to Participate at the William Blair Late-Stage Therapeutics Conference
  14. Pfenex to Present at the 18th Annual Needham Healthcare Conference
  15. Pfenex to Present at the 29th Annual Oppenheimer & Co. Healthcare Conference
  16. Pfenex Appoints Dr. Martin B. Brenner as Chief Scientific Officer
  17. Will Pfenex Continue to Surge Higher?
  18. Edited Transcript of PFNX earnings conference call or presentation 11-Mar-19 8:30pm GMT
  19. Pfenex (PFNX) Reports Q4 Loss, Misses Revenue Estimates
  20. Pfenex Reports Fourth Quarter and Full Year 2018 Results and Provides Business Update